Drug prices could soar after pay-for-delay ruling, critics say

06/23/2013 | Time.com

The Supreme Court ruling allowing the Federal Trade Commission to legally challenge patent settlements can help patients save millions in medication costs only if less-expensive generic drugs reach pharmacy shelves. However, the verdict could delay generics even further if generic-drug-makers fear lengthy, expensive legal challenges, critics of the ruling say.

View Full Article in: